(Press-News.org) NEW YORK (Nov. 3, 2010) -- Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
Researchers at Weill Cornell Medical College have found a combination therapy that is more effective than traditional treatments and is able to kill the cancer cells without harm to surrounding tissues. In a paper published in the Journal of Clinical Investigation on Nov. 1, they report that by targeting a key lymphoma-causing factor called BCL6 with a specific inhibitor called RI-BPI in combination with either a histone deacetylases (HDAC) inhibitor or with a heat shock protein (Hsp90) inhibitor, they were able to suppress and in some cases eradicate human DLBCL in mice. The researchers said their findings provide the basis for rational, targeted combinational therapy for patients with DLBCL.
Dr. Ari Melnick, associate professor of medicine and director of the Raymond and Beverly Sackler Center for Biomedical and Physical Sciences at Weill Cornell Medical College, and his colleagues have been studying ways to kill lymphoma cancer cells more effectively and efficiently than standard treatments.
"Lymphomas are not easy to treat. The standard treatment using monoclonal antibodies and chemotherapy does not work for all patients and can cause undesirable side effects," says Dr. Melnick.
B cells are a type of white blood cell that produces antibodies to fight infections. BCL6 is a master regulatory factor that plays a critical role in keeping lymphoma cells alive. Dr. Melnick's study showed that therapeutic targeting of BCL6 with RI-BPI turned on another factor called EP300, a molecular switch that itself can turn on proteins that can restrain lymphoma cell growth and turn off other proteins that help lymphoma cells. The research team showed that turning on EP300 made lymphomas much more sensitive to the HDAC and Hsp90 inhibitors. Administering the drugs together is like "kicking both legs" of the lymphoma cells, so they cannot regain their balance. Thus, the combined effect of the drugs is much greater than either drug alone and has very powerful anti-tumor effects. In contrast, normal cells and tissues are not damaged by this form of combination therapy, since they are not dependent on these two "legs."
Finally, the scientists also discovered that EP300 is sometimes mutated in lymphomas, which shows that this gene may normally protect B cells from becoming cancerous. Detection of these mutations in patients is important since such tumors may not be responsive to RI-BPI. Dr. Melnick says that there is much more work to be done but he hopes that his research will lead to a better understanding of the mechanisms of cancer at the cellular level and better treatments for lymphomas and other cancers.
INFORMATION:
This research was supported by the Leukemia and Lymphoma Society and the Chemotherapy Foundation.
Besides Dr. Melnick, contributing authors to the paper included Leandro C. Cerchietti, Katerina Chatzi, Shao-Ning Yang, Maria E. Figueroa, Lourdes Mendez and Rita Shaknovich from Weill Cornell Medical College; Eloisi Caldas-Lopes, Sloan-Kettering Institute; Philip Cole, Johns Hopkins University School of Medicine; Kapil Bhalla, Medical College of Georgia Cancer Center, Augusta, Ga.; and Randy D. Gascoyne, Martin Hirst and Marco Marra, British Columbia Cancer Agency, Vancouver, Canada.
The Raymond and Beverly Sackler Center for Biomedical and Physical Sciences
The Raymond and Beverly Sackler Center for Biomedical and Physical Sciences of Weill Cornell Medical College brings together a multidisciplinary team of scientists for the purpose of catalyzing major advances in medicine. By harnessing the combined power of experimental approaches rooted in the physical and biological sciences, Sackler Center investigators can best accelerate the pace of discovery and translate these findings for the benefit of patients with various medical conditions including but not limited to cancer.
Weill Cornell Medical College
Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances -- including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with the Methodist Hospital in Houston, making Weill Cornell one of only two medical colleges in the country affiliated with two U.S.News & World Report Honor Roll hospitals. For more information, visit www.med.cornell.edu.
END
CINCINNATI—Researchers at the University of Cincinnati (UC) and the Cincinnati Veterans Affairs (VA) Medical Center have found that about one-third of chronic kidney disease patients who are prescribed therapies for high blood pressure do not often adhere to treatments.
This report was published in the Nov. 2 online edition of the American Journal of Nephrology.
The study, led by researchers at UC and the Cincinnati VA, showed that treatment of hypertension in patients with chronic kidney disease continues to be a challenge in their care and that by simply improving ...
Researchers at Mount Sinai School of Medicine have found that 98 percent of the U.S. population lives in communities within 60 minutes of a hospice provider, suggesting that disparities in use of hospice are not likely due to a lack of access to a hospice provider. The results are published in the current issue of the Journal of Palliative Medicine.
"Despite a significant increase in the availability of hospice services during the past decade, the majority of Americans die without hospice care," said Melissa D.A. Carlson, PhD, Assistant Professor of Geriatrics and Palliative ...
VIDEO:
Video opens with footage of a common cornstarch and water experiment. Ian Oberst, a visiting student from Portland Community College who participated in the University of Oregon's UCORE program for...
Click here for more information.
Mix two parts cornstarch and one part water. Swirl your fingers in it slowly and the mixture is a smoothly flowing liquid. Punch it quickly with your fist and you meet a rubbery solid -- so solid you can jump up and down on a vat of it.
It ...
Melt water flowing through ice sheets via crevasses, fractures and large drains called moulins can carry warmth into ice sheet interiors, greatly accelerating the thermal response of an ice sheet to climate change, according to a new study involving the University of Colorado at Boulder.
The new study showed ice sheets like the Greenland Ice Sheet can respond to such warming on the order of decades rather than the centuries projected by conventional thermal models. Ice flows more readily as it warms, so a warming climate can increase ice flows on ice sheets much faster ...
New Haven, Conn.—While sorting through hundreds of galaxy images as part of the Galaxy Zoo citizen science project two years ago, Dutch schoolteacher and volunteer astronomer Hanny van Arkel stumbled upon a strange-looking object that baffled professional astronomers. Two years later, a team led by Yale University researchers has discovered that the unique object represents a snapshot in time that reveals surprising clues about the life cycle of black holes.
In a new study, the team has confirmed that the unusual object, known as Hanny's Voorwerp (Hanny's "object" in ...
Positive psychological changes that occur during meditation training are associated with greater telomerase activity, according to researchers at the University of California, Davis, and the University of California, San Francisco. The study is the first to link positive well-being to higher telomerase, an enzyme important for the long-term health of cells in the body.
The effect appears to be attributable to psychological changes that increase a person's ability to cope with stress and maintain feelings of well-being.
"We have found that meditation promotes positive ...
LOS ALAMOS, New Mexico, NOVEMBER 3, 2010—Scientists at the U.S. Department of Energy's Los Alamos National Laboratory and Brookhaven National Laboratory have fabricated transparent thin films capable of absorbing light and generating electric charge over a relatively large area. The material, described in the journal Chemistry of Materials, could be used in development of transparent solar panels.
"Potentially, with future refinement of this technology, windows in a home or office could generate solar power," said Hsing-Lin Wang, a co-corresponding author of the paper ...
Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study by researchers from the RAND Corporation and the Institute for Fiscal Studies in London.
Researchers found that while Americans aged 55 to 64 have higher rates of chronic diseases than their peers in England, they died at about the same rate. And Americans age 65 and older -- while still sicker than their English peers -- had a lower death rate than similar people in England, according to findings published in the journal ...
A large population-based study revealed that multiple antiepileptic drugs (AEDs) used by pregnant women to control seizures may cause poor school performance in their teenagers. The research team from Karolinska University Hospital and the University of Lund in Sweden confirmed that exposure to AEDs in utero may have a negative effect on neurodevelopment. Their findings now appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
Prior studies suggest that exposure to AEDs in utero may cause permanent ...
Chevy Chase, MD—Today, The Endocrine Society released a new clinical practice guideline for the nutritional and endocrine management of adults after bariatric surgery, including those with diabetes mellitus. The guideline features a series of evidence-based clinical recommendations developed by an expert task force. The guideline is published in the November 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
Between 1999 and 2004, obesity rates in the United States increased by 24 percent. Bariatric surgery ...
